title: [Modern Lipid therapy today and tomorrow: anti-PCSK9 : A magic bullet concept following Paul Ehrlich].
authors.affiliation: Institut für medizinische Informatik, Biometrie und Epidemilogie (IMIBE), Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland. Raimund.Erbel@uk-essen.de.
authors.forename: R
authors.initials: R
authors.lastname: Erbel
authors.affiliation: Institut für Herzinfarktforschung Ludwigshafen und Medizinische Klinik B, Klinikum Ludwigshafen, Bremserstr. 79, 67063, Ludwigshafen, Deutschland.
authors.forename: A K
authors.initials: AK
authors.lastname: Gitt
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000276:immunology*; D058990:Molecular Targeted Therapy / Q000379:methods; D000091362:PCSK9 Inhibitors; D000071449:Proprotein Convertase 9 / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D000091362:PCSK9 Inhibitors; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9